Antje Richter

9PUBLICATIONS
17CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 14, 2026
A Bioinformatics and Wet-Lab-Based Pipeline Identifies CLDN10 and GJB2 as Epigenetically Silenced Tumor Suppressor Genes in Cutaneous Melanoma.

Sarah Arroyo Villora, Veit Xaver Baumann, Yufen Zhao

|Nov 27, 2024
Kv3.3 Expression Enhanced by a Novel Variant in the Kozak Sequence of KCNC3.

Marlen Colleen Reis, Frauke Härtel, Antje Maria Richter

|Feb 24, 2024
Biomarker RIPK3 Is Silenced by Hypermethylation in Melanoma and Epigenetic Editing Reestablishes Its Tumor Suppressor Function.

Sarah Arroyo Villora, Paula Castellanos Silva, Tamara Zenz

|Sep 28, 2023
BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach.

Yassire Oubaddou, Mohamed Oukabli, Salma Fenniche

|Jul 28, 2022
Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner.

Michelle L Woods, Astrid Weiss, Anna M Sokol

|Dec 01, 2020
Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis.

Miriam M Küster, Marc A Schneider, Antje M Richter

Pageof 2

Frequent Collaborators

4 joint publications

Reinhard Heinrich Dammann

2 joint publications

Sarah Arroyo Villora

1 joint publications

Marc A Schneider

1 joint publications

Sarah Richtmann